LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.
Yeboah M, Papagregoriou C, Jones DC, Chan HTC, Hu G, McPartlan JS, Schiött T, Mattson U, Mockridge CI, Tornberg UC, Hambe B, Ljungars A, Mattsson M, Tews I, Glennie MJ, Thirdborough SM, Trowsdale J, Frendeus B, Chen J, Cragg MS, Roghanian A.
Yeboah M, et al. Among authors: roghanian a.
JCI Insight. 2020 Sep 1;5(18):e141593. doi: 10.1172/jci.insight.141593.
JCI Insight. 2020.
PMID: 32870822
Free PMC article.